More than a hundred thousand women diagnosed with breast cancer in Europe and the US each year could avoid chemotherapy by taking a gene test made by Agendia, a Dutch biotech group, which can attempt to predict whether the disease is likely to return.
通过接受一家荷兰生物科技集团Agendia开发的一项基因测试，每年确诊患有乳腺癌的逾10万名欧美女性可能不必接受化疗。Agendia可以尝试预测癌症有无复发可能。
您已阅读12%（332字），剩余88%（2487字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。